82 related articles for article (PubMed ID: 22100655)
1. Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo.
Gurtner K; Hessel F; Eicheler W; Dörfler A; Zips D; Heider KH; Krause M; Baumann M
Radiother Oncol; 2012 Mar; 102(3):444-9. PubMed ID: 22100655
[TBL] [Abstract][Full Text] [Related]
2. A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus.
Tijink BM; Buter J; de Bree R; Giaccone G; Lang MS; Staab A; Leemans CR; van Dongen GA
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6064-72. PubMed ID: 17062682
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck.
Sauter A; Kloft C; Gronau S; Bogeschdorfer F; Erhardt T; Golze W; Schroen C; Staab A; Riechelmann H; Hoermann K
Int J Oncol; 2007 Apr; 30(4):927-35. PubMed ID: 17332932
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma.
Riechelmann H; Sauter A; Golze W; Hanft G; Schroen C; Hoermann K; Erhardt T; Gronau S
Oral Oncol; 2008 Sep; 44(9):823-9. PubMed ID: 18203652
[TBL] [Abstract][Full Text] [Related]
5. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.
Krause M; Schütze C; Petersen C; Pimentel N; Hessel F; Harstrick A; Baumann M
Radiother Oncol; 2005 Feb; 74(2):109-15. PubMed ID: 15734198
[TBL] [Abstract][Full Text] [Related]
6. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
Schütze C; Bergmann R; Yaromina A; Hessel F; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2007 Jun; 83(3):311-5. PubMed ID: 17502117
[TBL] [Abstract][Full Text] [Related]
7. Decreased repopulation as well as increased reoxygenation contribute to the improvement in local control after targeting of the EGFR by C225 during fractionated irradiation.
Krause M; Ostermann G; Petersen C; Yaromina A; Hessel F; Harstrick A; van der Kogel AJ; Thames HD; Baumann M
Radiother Oncol; 2005 Aug; 76(2):162-7. PubMed ID: 16024114
[TBL] [Abstract][Full Text] [Related]
8. EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells?
Krause M; Prager J; Zhou X; Yaromina A; Dörfler A; Eicheler W; Baumann M
Radiother Oncol; 2007 Jun; 83(3):316-25. PubMed ID: 17531334
[TBL] [Abstract][Full Text] [Related]
9. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
Schreiber A; Krause M; Zips D; Dörfler A; Richter K; Vettermann S; Petersen C; Beuthien-Baumann B; Thümmler D; Baumann M
Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873
[TBL] [Abstract][Full Text] [Related]
10. Effect of cetuximab and fractionated irradiation on tumour micro-environment.
Santiago A; Eicheler W; Bussink J; Rijken P; Yaromina A; Beuthien-Baumann B; van der Kogel AJ; Baumann M; Krause M
Radiother Oncol; 2010 Nov; 97(2):322-9. PubMed ID: 20667608
[TBL] [Abstract][Full Text] [Related]
11. Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
Börjesson PK; Postema EJ; Roos JC; Colnot DR; Marres HA; van Schie MH; Stehle G; de Bree R; Snow GB; Oyen WJ; van Dongen GA
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3961S-72S. PubMed ID: 14506195
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma.
Krause M; Hessel F; Zips D; Hilberg F; Baumann M
Radiother Oncol; 2004 Jul; 72(1):95-101. PubMed ID: 15236881
[TBL] [Abstract][Full Text] [Related]
13. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
15. Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study.
Rupp U; Schoendorf-Holland E; Eichbaum M; Schuetz F; Lauschner I; Schmidt P; Staab A; Hanft G; Huober J; Sinn HP; Sohn C; Schneeweiss A
Anticancer Drugs; 2007 Apr; 18(4):477-85. PubMed ID: 17351401
[TBL] [Abstract][Full Text] [Related]
16. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
[TBL] [Abstract][Full Text] [Related]
17. Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas.
Zips D; Le K; Yaromina A; Dörfler A; Eicheler W; Zhou X; Geyer P; Hilberg F; Baumann M
Radiother Oncol; 2009 Sep; 92(3):405-10. PubMed ID: 19409639
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
el-Said A; Menke D; Dorie MJ; Brown JM
Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
[TBL] [Abstract][Full Text] [Related]
19. Experimental study on different combination schedules of VEGF-receptor inhibitor PTK787/ZK222584 and fractionated irradiation.
Zips D; Krause M; Hessel F; Westphal J; Brüchner K; Eicheler W; Dörfler A; Grenman R; Petersen C; Haberey M; Baumann M
Anticancer Res; 2003; 23(5A):3869-76. PubMed ID: 14666690
[TBL] [Abstract][Full Text] [Related]
20. Tumour-infiltrating CD11b+ myelomonocytes and response to fractionated irradiation of human squamous cell carcinoma (hSCC) xenografts.
Zaleska K; Bruechner K; Baumann M; Zips D; Yaromina A
Radiother Oncol; 2011 Oct; 101(1):80-5. PubMed ID: 21724288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
